│Home│Sitemap│Notes for Usage│Inquiry│日本語│

■IR News 13/06/07 Announcement of Delisting and Arrangement of Shares 13/05/10 Announcement of Resolution in Extraordinary Shareholders’ Meeting and Applying Delisting from TOKYO PRO Market 13/04/25 Announcement of Extraordinary Shareholders’ Meeting for Applying Delisting from TOKYO PRO Market 13/03/27 Announcement of Applying for Delisting from TOKYO PRO Market 13/02/12 Announcement of Developing Contrast Agent Using Nano-particle for Ultrasound Contrast 12/06/01 Starting a Clinical Study for Pancreatic Cancer 12/03/26 Replacement of Accounting Auditor (PDF in Japanese) 12/02/20 Joint Venture Establishment in Sri Lanka 11/12/07 Joint press conference on a joint venture in Sri Lanka(pdf in Japanese) 11/12/07 Announcement of establishing a joint venture in Sri Lanka (pdf in Japanese) 11/09/02 Mebiopharm analyst report is publised by Phillip Securities Ltd. 11/07/15 Mebiopharm applied for listing on TOKYO AIM  ■Stock Information As of 31th March, 2015　 Number of shares issued 3,275,800 1 unit of shares 100 Number of Shareholders 35 Handling Office Corporate Strategy Office Mebiopharm Co., Ltd. ARK Hills Executive Tower 8th Floor 1-14-5, Akasaka, Minato-ku, Tokyo, 107-0052  ■Other Information